Graviton Bioscience Funding: $10M Raised, Series A (2024)
Graviton Bioscience is based in New York, NY. It has raised $10M in total funding. Latest round: Series A.
Graviton Bioscience funding overview
Graviton Bioscience is based in New York, NY. Graviton Bioscience has raised $10M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series A announced in January 2024. The round record for Graviton Bioscience runs through 2024; nothing later has been disclosed. Investors on record include Sanofi, Enavate Sciences, Ovid Therapeutics. 3 distinct backers are named across the disclosed rounds.
Graviton Bioscience at a glance
Total raised
$10M
Latest round
Series A
Latest round date
January 2024
Headquarters
New York, NY
Notable investors
Sanofi, Enavate Sciences, Ovid Therapeutics
Frequently asked about Graviton Bioscience funding
How much has Graviton Bioscience raised?
Graviton Bioscience has raised $10M in total disclosed funding across the rounds on record.
Who has invested in Graviton Bioscience?
Sanofi, Enavate Sciences, Ovid Therapeutics are named among the investors backing Graviton Bioscience.
What was the latest Graviton Bioscience funding round?
The most recent disclosed round is a Series A, announced in January 2024.
Where is Graviton Bioscience based?
Graviton Bioscience is based in New York, NY.
When did Graviton Bioscience last raise?
The last disclosed Graviton Bioscience round closed in January 2024 at Series A.
We update the Graviton Bioscience record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in New York and their backers are listed below.
